Type your tag names separated by a space and hit enter
Screening for type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
"Screening for Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431749/all/Creatine_for_treating_muscle_disorders_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 04 October 2023.
Screening for type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431749/all/Creatine_for_treating_muscle_disorders_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed October 4, 2023.
Screening for type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431749/all/Creatine_for_treating_muscle_disorders_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Screening for Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2023 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431749/all/Creatine_for_treating_muscle_disorders_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Screening for type 2 diabetes mellitus
ID - 431749
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431749/all/Creatine_for_treating_muscle_disorders_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
Try the app for free!
1. Download the Evidence Central app by Unbound Medicine
2. Select Try/Buy and follow instructions to begin your free 30-day trial
You can cancel anytime within the 30-day trial, or continue using Evidence Central to begin a 1-year subscription ($39.95)
Your free 1 year of online access expired .
Want to regain access to Evidence Central?
Log in to Evidence Central
If you need further assistance, please contact Support.